Wen-Chai Tsai

Wen-Chai Tsai

Auto-generated profile, based on publicly available information

Wen-Chai Tsai

Department of Internal Medicine and Center for Infection Control, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2024 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
TYTian-Yu You
Tian-Yu You
CLChing-Lung Lo
Ching-Lung Lo
WTWen-Chia Tsai
Wen-Chia Tsai
HJHAOEN JAN
HAOEN JAN
WKWen-Chien Ko
Wen-Chien Ko
NLNan-Yao Lee
Nan-Yao Lee
As limited antibiotic options are available for the treatment of carbapenem-resistant Klebsiella pneumoniae (CRKP) bloodstream infections (BSIs), the optimal treatment duration for CRKP BSIs is unclear. Our objective was to investigate whether short courses (6-10 days) are as effective as prolonged courses (≥11 days) of active antibiotic therapy for CRKP BSIs. A retrospective cohort study comprising adults with monomicrobial CRKP BSI receiving a short or prolonged course of in vitro active therapy at a medical center was conducted between 2010 and 2021. Comparisons of two therapeutic strategies were assessed by the logistic regression model and propensity score analysis. The primary endpoint was 30-day crude mortality. Secondary outcomes included recurrent BSIs, the emergence of multidrug-resistant organisms and candidemia during hospitalization after completing antibiotic therapy for CRKP BSIs. Of 263 eligible adults, 160 (60.8%) were male, and the median (interquartile range) age was 69.0 (53.0-76.0) years. Common comorbidities included diabetes (143 patients, 54.4%), malignancy (75, 28.5%), cerebrovascular accident (58, 22.1%), and hemodialysis (49, 18.6%). The 30-day mortality rate was 8.4% (22 patients). Of 84 propensity score well-balanced matched pairs, the 30-day mortality was similar in the short-course and prolonged-course group (6.0% and 7.1%, respectively; P = 1.00). However, there were less episodes candidemia in the short-course group (1.2% versus 13.1%; odds ratio, 0.08; 95% confidence interval, 0.01-0.63; P = 0.005). Short courses of active therapy for CRKP BSIs demonstrate comparable clinical outcomes to prolonged courses and are associated with a lower risk of subsequent candidemia.

1 December 2021 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
WTWen-Chai Tsai
Wen-Chai Tsai
PTPei-Jane Tsai
Pei-Jane Tsai
BTBo-Yang Tsai
Bo-Yang Tsai
CTChin-Shiang Tsai
Chin-Shiang Tsai
PCPo-Lin Chen
Po-Lin Chen
LSLing-Shan Syue
Ling-Shan Syue